Ethical aspects of creating clinical guidelines for practitioners

Author:

Dreytser ED1,Mudrova AV1,Pavlov ChS2

Affiliation:

1. The First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Moscow, Russia

2. Botkin City Clinical Hospital, Moscow, Russia

Abstract

Clinical guidelines represent documents that contain structured information based on scientific evidence on prevention, diagnosis, treatment and rehabilitation, and regulate professional activities of the medical community. Starting from January 1, 2025, it is planned to switch to the mandatory use of clinical recommendations approved by the Ministry of Health of the Russian Federation, while the year of 2024 is an interim period for their application. However, various methodological and ethical issues arise while developing and discussing clinical recommendations. They include a conflict of interests of the authors, as well as aspects of its disclosure and settlement, accessibility of clinical recommendations for patients, as well as the discrepancy between the provisions of the recommendations and their evidence base such as results of systematic reviews and meta-analyses. Resolution of these problems will significantly improve the quality of clinical recommendations, and increase patient awareness of diseases and treatment approaches. This review analyzes a wide range of methodological problems related to the development of clinical recommendations, examines regulatory acts and ethical principles issued by government agencies, professional communities and international organizations, and makes suggestions to reduce the level of bias and, as a result, to increase the degree of evidence of clinical recommendations.

Publisher

Pirogov Russian National Research Medical University

Reference12 articles.

1. Federal’nyy zakon ot 21 noyabrya 2011 g. № 323-FZ «Ob osnovakh okhrany zdorov’ya grazhdan v Rossiyskoy Federatsii». Available from URL: https://minzdrav.gov.ru/documents/7025-federalnyy-zakon-323-fz-ot-21-noyabrya-2011-g (accessed: 12.05.2024). Russian.

2. Postanovleniye Pravitel’stva Rossiyskoy Federatsii ot 14.03.2024 № 299 Ofitsial’noye opublikovaniye pravovykh aktov. Available from URL: http://publication.pravo.gov.ru/document/0001202403220061 (accessed: 12.05.2024). Russian.

3. Jacoline Bouvy programme director medicines evaluation How NICE manages the potential conflicts of interests of patient experts. Blogs. News. NICE. Available from URL: https://www.nice.org.uk/news/blog/how-nice-manages-the-potential-conflicts-of-interests-of-patient-experts (accessed: 05.02.2024).

4. Qaseem A, et al. Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods from the Clinical Guidelines Committee of the American College of Physicians. Annals of Internal Medicine. 2019; 171(5): 354–361.

5. WHO handbook for guideline development, 2nd Edition. Available from URL: https://www.who.int/publications-detail-redirect/9789241548960 (accessed: 04.02.2024).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3